-
November 4: The Week in Cancer News
Female patients less likely than men to be told about sexual side effects of treatment, and independent analysis finds cancer-causing chemical in dry shampoo.
by Marci A. Landsmann
-
October 28: The Week in Cancer News
Clinical trial finds select breast cancer patients can forgo surgery, and cancer organizations warn of growing e-cigarette use among teens.
by Thomas Celona
-
October 21: The Week in Cancer News
Chemical hair straightening is associated with higher uterine cancer risk, and gas stoves can leak chemicals linked to cancer.
by Eric Fitzsimmons
-
October 14: The Week in Cancer News
Colonoscopy study results are misreported, and progress is seen in cancer vaccines.
by Kevin McLaughlin
-
October 7: The Week in Cancer News
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
by Marci A. Landsmann
-
September 30: The Week in Cancer News
Firefighters face increased cancer risk due to exposure to ‘forever chemicals,’ and cancer-related fatigue can put breast cancer survivors at risk for falls.
by Thomas Celona
-
September 23: The Week in Cancer News
AACR Cancer Progress Report 2022 shows continued decline in cancer death rates, and genetic tests create opportunities but also confusion for breast cancer patients.
by Eric Fitzsimmons
-
September 16: The Week In Cancer News
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain
by Marci A. Landsmann
-
September 9: The Week in Cancer News
Early-onset cancer is increasing globally, and testing population-wide preventive DNA testing.
by Kevin McLaughlin
-
September 2: The Week in Cancer News
Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
by Thomas Celona
Cancer Talk
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin